Skip to main content

Advertisement

Table 1 Baseline characteristics of all HCC patients

From: Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation

Characteristics Value
Patients 616
Pre-TACE 145 (23.5)
Age (yrs.) 56.0 (18.0)
Male 556 (90.3)
Ablation
 Radiofrequency 469 (76.1)
 Microwave 147 (23.9)
Tumor number
 Single 499 (81.0)
 Multiple 117 (19.0)
Tumor size (cm)
 ≤ 3 473 (76.8)
 > 3 143 (23.2)
Risk area 159 (25.8)
AFP ≥200 ng/ml 187 (30.4)
Hb (109/L) 142.0 (22.3)
PLT (109/L) 121.0 (90.0)
RBC (109/L) 4.6 (0.8)
WBC (109/L) 5.2 (2.5)
ALB (g/L) 41.5 (6.0)
ALT (U/L) 35.2 (26.8)
AST (U/L) 33.6 22.57)
TBIL (μmol/L) 15.0 (20.4)
Child-Pugh grade
 A 594 (96.4)
 B 22 (3.6)
PT (seconds) 12.3 (1.8)
Viral hepatitis 574 (93.2)
Cirrhosis 503 (81.7)
  1. Abbreviations: TACE Transcatheter arterial chemoembolization, AFP alpha-fetoprotein, Hb Hemoglobin, PLT platelet, RBC red blood cell, WBC white blood cell, ALB albumin, ALT alanine aminotransferase, AST aspartate aminotransferase, TBIL total bilirubin, PT prothrombin time
  2. Values are presented as the median (IQR) or n (%)